Compare Eli Lilly And Co (LLY) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs SMX Security Matters plc — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while SMX Security Matters plc trades at $3.79 (market cap $4.13M). The key difference: Eli Lilly And Co is far larger — about 251816× SMX Security Matters plc's market cap, and Eli Lilly And Co pays a 0.59% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and SMX Security Matters plc for 21 Days on average.
| LLY | SMX | |
|---|---|---|
Market Cap | $1.04T | $4.13M |
Volume | 3,064,878 | 124,362 |
Sector | Health | Industrials |
52-Week High | $1.28K | $74.08K |
52-Week Low | $799.57 | $3.79 |
Typical Hold Time | 93 Days | 21 Days |
Enterprise Value | $1.09T | -$27.20M |
Dividend Yield | 0.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company demonstrates exceptional profitability with 83.4% gross margins and 33.53% net income margins, supported by dominant positioning in weight-loss and diabetes treatments. Recent clinical trial successes for next-generation drugs and expanded FDA approvals reinforce growth prospects.
LLY presents compelling growth potential with analyst consensus target of $1,350 representing 15% upside, though elevated valuations (P/E 39.26) and increasing competition in obesity drugs pose risks. Strong institutional support (73% buy ratings) and positive pipeline developments support continued momentum, but investors should monitor execution risks and market saturation concerns.
SMX trades at $3.79, down 2.82% today, amid a bearish technical signal from moving averages despite oversold RSI readings. The company reported no revenue for 2025, with a net loss of $169.18 million and negative cash flow from operations, though financing activities provided a net cash inflow. Recent news highlights SMX's focus on recycled plastic verification and digital material passports, gaining media attention from outlets like Forbes and the Boston Herald in late 2026.
The outlook is highly speculative given the absence of revenue and deep losses; investment hinges on successful commercialization of its technology. Key risks include execution challenges, cash burn, and competitive pressures in the recycling sector. Analyst sentiment is cautious due to the lack of profitability and substantial financial deficits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
